Across TCGA pan-cancer cohorts, WDR25 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated WDR25 data layer compared with 21 for mass-spec protein and 6 for mutation status.
The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher WDR25 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated WDR25 expression acts as an unfavorable survival marker, although some lineages such as GBM and LUAD show a favorable association.
LSCC, GBM, and PDAC are the cancer types where WDR25 mass-spec protein most reproducibly stratifies survival.